arrow
M

Miriam Erlacher

University of Freiburg
H指数:33
被引数:4,876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparable outcomes of HSCT upfront and after failure of IST in pediatric aplastic anemia in recent years

近年来小儿再生障碍性贫血IST治疗前后HSCT的可比性结果

2026-01-220
OAAI
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function

白细胞中人E3泛素连接酶CBL的体细胞缺陷会损害b细胞,但不会损害T细胞的发育和功能

2026-01-150
OAAI
GENETIC LANDSCAPE AND OUTCOMES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH THERAPY-RELATED MYELOID NEOPLASMS

治疗相关性髓系肿瘤儿童和青少年造血干细胞移植后的遗传景观和结局

2025-11-010
OA
OUTCOMES OF RABBIT VS. HORSE ANTI-THYMOCYTE GLOBULIN IN IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY CYTOPENIA OF CHILDHOOD
2025-11-010
OAAI
LONG-TERM OUTCOME OF AN OBSERVATIONAL APPROACH IN PATIENTS WITH NRAS-MUTATED JUVENILE MYELOMONOCYTIC LEUKEMIA AND ABSENCE OF HIGH RISK FEATURES
2025-11-010
OA
REFRACTORY CYTOPENIA OF CHILDHOOD WITH NORMAL KARYOTYPE: LONG-TERM RESULTS OF AN OBSERVATIONAL APPROACH
2025-11-010
OA
PUMA-induced apoptosis drives bone marrow failure and genomic instability in telomerase-deficient mice

PUMA诱导的细胞凋亡导致端粒酶缺陷小鼠的骨髓衰竭和基因组不稳定性

2025-08-190
OA
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study

评估外周血DNA甲基化特征作为阿扎胞苷治疗儿童髓系单核细胞白血病期间药效学和预测性生物标志物的应用:EWOG-MESRAT研究的结果

2025-07-310
OAAI